<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34772336</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">1480-9222</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
              <Day>12</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biological procedures online</Title>
          <ISOAbbreviation>Biol Proced Online</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Heregulin Activity Assays for Residual Testing of Cell Therapy Products.</ArticleTitle>
        <Pagination>
          <StartPage>22</StartPage>
          <MedlinePgn>22</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">22</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12575-021-00157-5</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Heregulin is a ligand for the protooncogene product ErbB/HER that acts as  a key mitogenic factor for human Schwann cells (hSCs). Heregulin is required for sustained hSC growth in vitro but must be thoroughly removed before cell collection for transplantation due to potential safety concerns. The goal of this study was to develop simple cell-based assays to assess the effectiveness of heregulin addition to and removal from aliquots of hSC culture medium. These bioassays were based on the capacity of a β1-heregulin peptide to elicit ErbB/HER receptor signaling in adherent ErbB2+/ErbB3+ cells.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Western blotting was used to measure the activity of three different β1-heregulin/ErbB-activated kinases (ErbB3/HER3, ERK/MAPK and Akt/PKB) using phospho-specific antibodies against key activating residues. The duration, dose-dependency and specificity of β1-heregulin-initiated kinase phosphorylation were investigated, and controls were implemented for assay optimization and reproducibility to detect β1-heregulin activity in the nanomolar range. Results from these assays showed that the culture medium from transplantable hSCs elicited no detectable activation of the aforementioned kinases in independent rounds of testing, indicating that the implemented measures can ensure that the final hSC product is devoid of bioactive β1-heregulin molecules prior to transplantation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These assays may be valuable to detect impurities such as undefined soluble factors or factors for which other biochemical or biological assays are not yet available. Our workflow can be modified as necessary to determine the presence of ErbB/HER, ERK, and Akt activators other than β1-heregulin using native samples, such as fresh isolates from cell- or tissue extracts in addition to culture medium.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Monje</LastName>
            <ForeName>Paula V</ForeName>
            <Initials>PV</Initials>
            <Identifier Source="ORCID">0000-0002-5274-9238</Identifier>
            <AffiliationInfo>
              <Affiliation>Stark Neurosciences Research Institute, Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA. pmonje@iu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bacallao</LastName>
            <ForeName>Ketty</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aparicio</LastName>
            <ForeName>Gabriela I</ForeName>
            <Initials>GI</Initials>
            <AffiliationInfo>
              <Affiliation>Stark Neurosciences Research Institute, Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigaciones Biotecnológicas "Rodolfo A. Ugalde", Universidad Nacional de San Martín and Consejo Nacional de Investigaciones Científicas y Técnicas (IIBio-UNSAM-CONICET), Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lalwani</LastName>
            <ForeName>Anil</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Cell and Gene Therapy CMC and Regulatory Advisor, Boulder, CO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Biol Proced Online</MedlineTA>
        <NlmUniqueID>100963717</NlmUniqueID>
        <ISSNLinking>1480-9222</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Autologous cell therapy</Keyword>
        <Keyword MajorTopicYN="N">ErbB/HER</Keyword>
        <Keyword MajorTopicYN="N">In vitro culture</Keyword>
        <Keyword MajorTopicYN="N">Kinase activation</Keyword>
        <Keyword MajorTopicYN="N">Peripheral nerve</Keyword>
        <Keyword MajorTopicYN="N">Phosphor- antibodies</Keyword>
        <Keyword MajorTopicYN="N">Quality control</Keyword>
        <Keyword MajorTopicYN="N">Residual testing</Keyword>
        <Keyword MajorTopicYN="N">Schwann cells</Keyword>
        <Keyword MajorTopicYN="N">Signal transduction</Keyword>
        <Keyword MajorTopicYN="N">Western blot</Keyword>
      </KeywordList>
      <CoiStatement>A portion of this work was described in Dietrich WD, Investigational New Drug Application for the use of autologous human Schwann Cells (IND # 14856), approved by the Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Cellular, Tissue and Gene Therapy (US) in 2012. P.V.M., K.B. and A.L. contributed work presented in IND 14856 while affiliated to The Miami Project to Cure Paralysis working under the leadership of Dr. Dalton Dietrich. P.V.M. is the founder of GliaBio LLC, a consulting company that focuses on basic and translational glial cell research. The authors of this article declare that the research described here was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>5</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34772336</ArticleId>
        <ArticleId IdType="pmc">PMC8590303</ArticleId>
        <ArticleId IdType="doi">10.1186/s12575-021-00157-5</ArticleId>
        <ArticleId IdType="pii">10.1186/s12575-021-00157-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Guidance for Industry. CGMP for Phase 1 Investigational Drugs. US Department of Health and Human Services; 2008. https://www.fda.gov/media/70975/download. Accessed 12 Mar 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Monje PV. The properties of human Schwann cells: lessons from in vitro culture and transplantation studies. Glia. 2020;68(4):797–810. doi: 10.1002/glia.23793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.23793</ArticleId>
            <ArticleId IdType="pubmed">32027424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guest J, Santamaria AJ, Benavides FD. Clinical translation of autologous Schwann cell transplantation for the treatment of spinal cord injury. Curr Opin Organ Transplant. 2013;18(6):682–689. doi: 10.1097/MOT.0000000000000026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOT.0000000000000026</ArticleId>
            <ArticleId IdType="pmc">PMC3864173</ArticleId>
            <ArticleId IdType="pubmed">24220051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bunge MB, Monje PV, Khan A, Wood PM. From transplanting Schwann cells in experimental rat spinal cord injury to their transplantation into human injured spinal cord in clinical trials. Prog Brain Res. 2017;231:107–33. 10.1016/bs.pbr.2016.12.012. Epub 2017 Mar 31. PMID: 28554394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28554394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levi AD, Burks SS, Anderson KD, Dididze M, Khan A, Dietrich WD. The use of autologous Schwann cells to supplement sciatic nerve repair with a large gap: first in human experience. Cell Transplant. 2016;25(7):1395–1403. doi: 10.3727/096368915X690198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3727/096368915X690198</ArticleId>
            <ArticleId IdType="pubmed">26610173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, et al.  The influence of heregulins on human Schwann cell proliferation. J Neurosci. 1995;15(2):1329–1340. doi: 10.1523/JNEUROSCI.15-02-01329.1995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.15-02-01329.1995</ArticleId>
            <ArticleId IdType="pmc">PMC6577846</ArticleId>
            <ArticleId IdType="pubmed">7869101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monje PV, Sant D, Wang G. Phenotypic and functional characteristics of human Schwann cells as revealed by cell-based assays and RNA-SEQ. Mol Neurobiol. 2018;55(8):6637–6660. doi: 10.1007/s12035-017-0837-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-017-0837-3</ArticleId>
            <ArticleId IdType="pmc">PMC6041199</ArticleId>
            <ArticleId IdType="pubmed">29327207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casella GT, Bunge RP, Wood PM. Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro. Glia. 1996;17(4):327–338. doi: 10.1002/(SICI)1098-1136(199608)17:4&lt;327::AID-GLIA7&gt;3.0.CO;2-W.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-1136(199608)17:4&lt;327::AID-GLIA7&gt;3.0.CO;2-W</ArticleId>
            <ArticleId IdType="pubmed">8856329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menard S, Casalini P, Campiglio M, Pupa SM, Tagliabue E. Role of HER2/neu in tumor progression and therapy. Cell Mol Life Sci. 2004;61(23):2965–2978. doi: 10.1007/s00018-004-4277-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-004-4277-7</ArticleId>
            <ArticleId IdType="pubmed">15583858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monje PV, Athauda G, Wood PM. Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation. J Biol Chem. 2008;283(49):34087–34100. doi: 10.1074/jbc.M802318200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M802318200</ArticleId>
            <ArticleId IdType="pmc">PMC2590688</ArticleId>
            <ArticleId IdType="pubmed">18799465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monje PV, Bartlett Bunge M, Wood PM. Cyclic AMP synergistically enhances neuregulin-dependent ERK and Akt activation and cell cycle progression in Schwann cells. Glia. 2006;53(6):649–659. doi: 10.1002/glia.20330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.20330</ArticleId>
            <ArticleId IdType="pubmed">16470843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monje PV, Soto J, Bacallao K, Wood PM. Schwann cell dedifferentiation is independent of mitogenic signaling and uncoupled to proliferation: role of cAMP and JNK in the maintenance of the differentiated state. J Biol Chem. 2010;285(40):31024–31036. doi: 10.1074/jbc.M110.116970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.116970</ArticleId>
            <ArticleId IdType="pmc">PMC2945593</ArticleId>
            <ArticleId IdType="pubmed">20634285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson KD, Guest JD, Dietrich WD, Bartlett Bunge M, Curiel R, Dididze M, Green BA, Khan A, Pearse DD, Saraf-Lavi E, Widerström-Noga E, Wood P, Levi AD. Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury. J Neurotrauma. 2017;34(21):2950–63. 10.1089/neu.2016.4895. Epub 2017 Mar 21. PMID: 28225648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28225648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravelo KM, Andersen ND, Monje PV. Magnetic-activated cell sorting for the fast and efficient separation of human and rodent Schwann cells from mixed cell populations. Methods Mol Biol. 2018;1739:87–109. doi: 10.1007/978-1-4939-7649-2_6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-7649-2_6</ArticleId>
            <ArticleId IdType="pubmed">29546702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen ND, Srinivas S, Pinero G, Monje PV. A rapid and versatile method for the isolation, purification and cryogenic storage of Schwann cells from adult rodent nerves. Sci Rep. 2016;6:31781. doi: 10.1038/srep31781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep31781</ArticleId>
            <ArticleId IdType="pmc">PMC4994039</ArticleId>
            <ArticleId IdType="pubmed">27549422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen ND, Monje PV. Isolation, culture, and cryopreservation of adult rodent Schwann cells derived from immediately dissociated teased fibers. Methods Mol Biol. 2018;1739:49–66. doi: 10.1007/978-1-4939-7649-2_4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-7649-2_4</ArticleId>
            <ArticleId IdType="pubmed">29546700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill CE, Hurtado A, Blits B, Bahr BA, Wood PM, Bartlett Bunge M, et al.  Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur J Neurosci. 2007;26(6):1433–1445. doi: 10.1111/j.1460-9568.2007.05771.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2007.05771.x</ArticleId>
            <ArticleId IdType="pubmed">17880386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bacallao K, Monje PV. Requirement of cAMP signaling for Schwann cell differentiation restricts the onset of myelination. PLoS One. 2015;10(2):e0116948. doi: 10.1371/journal.pone.0116948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0116948</ArticleId>
            <ArticleId IdType="pmc">PMC4338006</ArticleId>
            <ArticleId IdType="pubmed">25705874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soto J, Monje PV. Axon contact-driven Schwann cell dedifferentiation. Glia. 2017;65(6):864–882. doi: 10.1002/glia.23131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.23131</ArticleId>
            <ArticleId IdType="pmc">PMC5395415</ArticleId>
            <ArticleId IdType="pubmed">28233923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinero G, Berg R, Andersen ND, Setton-Avruj P, Monje PV. Lithium reversibly inhibits Schwann cell proliferation and differentiation without inducing myelin loss. Mol Neurobiol. 2017;54(10):8287–8307. doi: 10.1007/s12035-016-0262-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-016-0262-z</ArticleId>
            <ArticleId IdType="pmc">PMC5459683</ArticleId>
            <ArticleId IdType="pubmed">27917448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monje PV. Schwann Cell Cultures: Biology, Technology and Therapeutics. Cells. 2020;9(8):1848. 10.3390/cells9081848. PMID: 32781699; PMCID: PMC7465416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7465416</ArticleId>
            <ArticleId IdType="pubmed">32781699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carraway KL, 3rd, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, et al.  The erbB3 gene product is a receptor for heregulin. J Biol Chem. 1994;269(19):14303–14306. doi: 10.1016/S0021-9258(17)36789-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9258(17)36789-3</ArticleId>
            <ArticleId IdType="pubmed">8188716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, et al.  Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem. 1994;269(20):14661–14665. doi: 10.1016/S0021-9258(17)36676-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9258(17)36676-0</ArticleId>
            <ArticleId IdType="pubmed">7514177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fornasari BE, El Soury M, Nato G, Fucini A, Carta G, Ronchi G, Crosio A, Perroteau I, Geuna S, Raimondo S, Gambarotta G. Fibroblasts Colonizing Nerve Conduits Express High Levels of Soluble Neuregulin1, a Factor Promoting Schwann Cell Dedifferentiation. Cells. 2020;9(6):1366. 10.3390/cells9061366. PMID: 32492853; PMCID: PMC7349576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7349576</ArticleId>
            <ArticleId IdType="pubmed">32492853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng K, Sant D, Andersen N, Silvera R, Camarena V, Pinero G, et al.  Magnetic separation of peripheral nerve-resident cells underscores key molecular features of human Schwann cells and fibroblasts: an immunochemical and transcriptomics approach. Sci Rep. 2020;10(1):18433. doi: 10.1038/s41598-020-74128-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-74128-3</ArticleId>
            <ArticleId IdType="pmc">PMC7595160</ArticleId>
            <ArticleId IdType="pubmed">33116158</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
